Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barna Dey

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Protocols in Immunology|April 25, 2008
Vaccinia-based reporter gene cell-fusion assays to quantitate functional interactions of HIV envelope glycoprotein with receptorsBarna Dey, Edward A Berger
Structure (London, England : 1993)|June 11, 2013
Blocking HIV-1 gp120 at the Phe43 cavity: if the extension fits…Barna Dey, Edward A Berger
Current Opinion in HIV and AIDS|February 25, 2015
Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infectionBarna Dey, Edward A Berger
Current HIV Research|January 3, 2014
Protein-based HIV-1 microbicidesBarna Dey, Laurel A Lagenaur, Paolo Lusso
Journal of Medical Primatology|February 22, 2026
Juvenile Nonhuman Primate Model: The Past, Present, and Future of a Preclinical Model System for Evaluating Development of New Pediatric Drug FormulationsBarna Dey, Hans Spiegel, James E Cummins
Journal of Virology|February 14, 2003
Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptorBarna Dey, Christie S Del Castillo, Edward A Berger
Retrovirology|February 18, 2010
sCD4-17b bifunctional protein: extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolatesLaurel A Lagenaur, Vadim A Villarroel, Virgilio Bundoc, et al.
Journal of Medicinal Chemistry|September 7, 2007
Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virusHui Xie, Danny Ng, Sergey N Savinov, et al.
Journal of Virology|September 26, 2014
Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodiesJidnyasa Ingale, Karen Tran, Leopold Kong, et al.
Journal of Virology|April 17, 2015
Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor ActivityLi Liu, Bhavik Patel, Mustafa H Ghanem, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Protocols in Immunology|April 25, 2008
Vaccinia-based reporter gene cell-fusion assays to quantitate functional interactions of HIV envelope glycoprotein with receptorsBarna Dey, Edward A Berger
Structure (London, England : 1993)|June 11, 2013
Blocking HIV-1 gp120 at the Phe43 cavity: if the extension fits…Barna Dey, Edward A Berger
Current Opinion in HIV and AIDS|February 25, 2015
Towards an HIV cure based on targeted killing of infected cells: different approaches against acute versus chronic infectionBarna Dey, Edward A Berger
Current HIV Research|January 3, 2014
Protein-based HIV-1 microbicidesBarna Dey, Laurel A Lagenaur, Paolo Lusso
Journal of Medical Primatology|February 22, 2026
Juvenile Nonhuman Primate Model: The Past, Present, and Future of a Preclinical Model System for Evaluating Development of New Pediatric Drug FormulationsBarna Dey, Hans Spiegel, James E Cummins
Journal of Virology|February 14, 2003
Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptorBarna Dey, Christie S Del Castillo, Edward A Berger
Retrovirology|February 18, 2010
sCD4-17b bifunctional protein: extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolatesLaurel A Lagenaur, Vadim A Villarroel, Virgilio Bundoc, et al.
Journal of Medicinal Chemistry|September 7, 2007
Structure-activity relationships in the binding of chemically derivatized CD4 to gp120 from human immunodeficiency virusHui Xie, Danny Ng, Sergey N Savinov, et al.
Journal of Virology|September 26, 2014
Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodiesJidnyasa Ingale, Karen Tran, Leopold Kong, et al.
Journal of Virology|April 17, 2015
Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor ActivityLi Liu, Bhavik Patel, Mustafa H Ghanem, et al.
Pageof 2